Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The triple A (AAA) model globally recapitulates adverse outcomes in essential thrombocythemia.
Tosoni L, Morelli GL, Tomadini G, Lazzarotto D, Filì C, Simeone E, Zannier ME, Callegari C, Fanin M, Battaglia G, Bergnach M, Damiani D, Fanin R, Tiribelli M. Tosoni L, et al. Among authors: lazzarotto d. Blood Cancer J. 2024 Oct 1;14(1):169. doi: 10.1038/s41408-024-01151-2. Blood Cancer J. 2024. PMID: 39353890 Free PMC article. No abstract available.
Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax.
Cordella S, Giusti D, De Bellis E, Dargenio M, Creti' F, Lazzarotto D, Cattaneo C, Fracchiolla NS, Piccini M, Forghieri F, Pagano L, Candoni A. Cordella S, et al. Among authors: lazzarotto d. Hematol Oncol. 2024 Sep;42(5):e3310. doi: 10.1002/hon.3310. Hematol Oncol. 2024. PMID: 39276390 No abstract available.
Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study.
Lazzarotto D, Cerrano M, Papayannidis C, Chiaretti S, Mosna F, Fracchiolla N, Zappasodi P, Imbergamo S, Del Principe MI, Lunghi M, Lussana F, Piccini M, Fumagalli M, Dargenio M, Salutari P, Forghieri F, Da Molin TG, Bonifacio M, Olivi M, Giglio F, Trappolini S, Leoncin M, Mule A, Delia M, Pasciolla C, Grimaldi F, Cambo B, Santoro L, Guolo F, Minetto P, Defina M, Chiusolo P, Fanin M, Mauro E, Aprile L, Mazzone C, Trastulli F, Ciccone M, De Gobbi M, Cignetti A, De Bellis E, Mancini V, Piciocchi A, Vignetti M, Marsili G, Starza ID, Fanin R, Luppi M, Ferrara F, Pizzolo G, Bassan R, Foa R, Candoni A. Lazzarotto D, et al. Haematologica. 2024 Aug 15. doi: 10.3324/haematol.2024.285638. Online ahead of print. Haematologica. 2024. PMID: 39157875 Free article.
Ponatinib alone or with chemo-immunotherapy in heavily pre-treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study.
Kaiser F, Lunghi M, Cardinali D, Bellomarino V, Beldinanzi M, Starza ID, Malfona F, Basilico CM, Defina M, Mastaglio S, Giglio F, Lazzarotto D, Salutari P, Piccini M, Cardinali V, Pierini A, Fracchiolla NS, Di Biase F, Annunziata M, Di Trani M, Foa R, Chiaretti S. Kaiser F, et al. Among authors: lazzarotto d. Haematologica. 2024 Aug 1. doi: 10.3324/haematol.2024.285258. Online ahead of print. Haematologica. 2024. PMID: 39086308 Free article.
Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission.
Candoni A, Chiusolo P, Lazzarotto D, Sartor C, Dargenio M, Chiaretti S, Skert C, Giglio F, Trappolini S, Fracchiolla NS, Medici S, Bresciani P, Cuoghi A, Papayannidis C. Candoni A, et al. Among authors: lazzarotto d. Cancers (Basel). 2024 May 31;16(11):2108. doi: 10.3390/cancers16112108. Cancers (Basel). 2024. PMID: 38893226 Free PMC article.
Correction to: Correlation between IPSET‑t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience.
Tosoni L, Liberi M, Morelli G, Zannier ME, Lazzarotto D, Filì C, Simeone E, Battaglia G, Callegari C, Fanin M, Damiani D, Fanin R, Tiribelli M. Tosoni L, et al. Among authors: lazzarotto d. Ann Hematol. 2024 Feb;103(2):449. doi: 10.1007/s00277-023-05608-5. Ann Hematol. 2024. PMID: 38157002 No abstract available.
Correlation between IPSET-t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience.
Tosoni L, Liberi M, Morelli G, Zannier ME, Lazzarotto D, Filì C, Simeone E, Battaglia G, Callegari C, Fanin M, Damiani D, Fanin R, Tiribelli M. Tosoni L, et al. Among authors: lazzarotto d. Ann Hematol. 2024 Feb;103(2):443-448. doi: 10.1007/s00277-023-05578-8. Epub 2023 Dec 11. Ann Hematol. 2024. PMID: 38072850
41 results